Development of a multivalent vibriosis vaccine and its application in sea cage farming of cobia

Ramesh Kumar, P and Nazar, A K A and Jayakumar, R and Tamilmani, G and Sakthivel, M and Sankar, M and Anikuttan, K K and Nazeera Begum, M and Sirajudeen, S and Rao, G Hanumanta (2020) Development of a multivalent vibriosis vaccine and its application in sea cage farming of cobia. Marine Fisheries Information Service, Technical and Extension Series, 246. pp. 29-33. ISSN ISSN 0254-380X

MFIS_246_P Rameshkumar.pdf

Download (421kB) | Preview
Related URLs:


    The loss due to diseases in the aquaculture sector is estimated to be around 10-15% of the production cost and it can be substantially reduced if due attention is given to scientific health management. Most of the antibiotics are banned in aquaculture, so the alternative to maintain fish health is based on the supplementation of probiotics, immunostimulants and administration of vaccines. The main objective of developing a multivalent vaccine against vibriosis is to prevent the seasonal epizootics in cultured cobia Rachycentron canadum. The whole cell inactivated multivalent vibrio vaccine against vibriosis was developed, standardized and evaluated in cobia fingerlings. The field application of the vaccine was studied in sea cages deployed for growout and broodstock rearing of cobia. The immune responses were evaluated by challenge studies in fingerlings and serum antibody titre in cobia growout and broodstock cages using ELISA. The regular epizootics observed in cage cultured cobia, every year during the months of July to September (pre-monsoon season) was prevented by timely vaccination and proper sea cage farming management.

    Item Type: Article
    Uncontrolled Keywords: Cobia, vibriosis, multivalent vaccine, cage farming
    Subjects: Aquaculture > Farming/Culture
    Aquaculture > Cage culture
    Fish and Fisheries > Fish Disease
    Demersal Fishes > Cobia
    Divisions: CMFRI-Mandapam
    Depositing User: Arun Surendran
    Date Deposited: 02 Mar 2021 09:49
    Last Modified: 18 May 2022 04:59

    Actions (login required)

    View Item View Item